Richard M. Pazdur
Richard M. Pazdur publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics, on topics such as Colorectal Cancer Treatments and Studies, Cancer Treatment and Pharmacology and Lung Cancer Treatments and Mutations.
- World rank
- #3,208 of 7,710,434 ranked researchers
- Rank in United States
- #1,117 of 1,627,098
- Works
- 1,062
- Citations
- 64k
- Citations per work
- 60.3
What does Richard M. Pazdur research?
Richard M. Pazdur's work is mostly in Medicine (47%), Biochemistry, Genetics and Molecular Biology (11%), Economics, Econometrics and Finance (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences50247.3%
- Medicine50247.3%
- Everything else36934.7%
- Life Sciences11711.0%
- Social Sciences747.0%
- 1Oncology28% of their works
- 2Pulmonary and Respiratory Medicine15% of their works
- 3Economics and Econometrics7% of their works
- 4Cancer Research6% of their works
- 5Hematology5% of their works
- 6Molecular Biology5% of their works
Research topics
Which keywords describe Richard M. Pazdur's research?
The keywords of their largest research topics: Quality of Life, Targeted Therapy, Metastatic Breast Cancer, Cetuximab, KRAS Mutations, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and ALK Inhibitors.
- CDK4/6 Inhibitors
- Adaptive Designs
- Cost-effectiveness Analysis
- Cancer Genomics
- Immune Checkpoint Blockade
- ALK Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- Cetuximab
- Targeted Therapy
- Quality of Life
- Metastatic Breast Cancer
- KRAS Mutations
- Taxanes
- EGFR Mutations
- PD-1 and PD-L1
- Mutational Signatures
- Health Utility Measures
- Breast Cancer
- False Discovery Rate
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Quality of Life2002 topics
- Targeted Therapy1902 topics
- Metastatic Breast Cancer1842 topics
- Cetuximab1431 topic
- KRAS Mutations1431 topic
- Chemotherapy-Induced Peripheral Neuropathy1211 topic
- Taxanes1211 topic
- ALK Inhibitors1021 topic
- EGFR Mutations1021 topic
- Immune Checkpoint Blockade971 topic
- PD-1 and PD-L1971 topic
- Cancer Genomics881 topic
- Mutational Signatures881 topic
- Cost-effectiveness Analysis791 topic
- Health Utility Measures791 topic
- Adaptive Designs631 topic
- Breast Cancer631 topic
- CDK4/6 Inhibitors631 topic
- False Discovery Rate631 topic
Where does Richard M. Pazdur work?
Richard M. Pazdur's main affiliation in the publication record is United States Food and Drug Administration, United States.
How many publications and citations does Richard M. Pazdur have?
OpenAlex counts 1,062 works and 63,991 citations for Richard M. Pazdur, an h-index of 136, ranking #3,208 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Richard M. Pazdur. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.